Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Angiogenesis ; 10(2): 89-101, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17372851

RESUMEN

Nothing more dramatically captures the imagination of the visually impaired patient or the ophthalmologist treating them than the possibility of rebuilding a damaged retina or vasculature with "stem cells." Stem cells (SC) have been isolated from adult tissues and represent a pool of cells that may serve to facilitate rescue/repair of damaged tissue following injury or stress. We propose a new paradigm to "mature" otherwise immature neovasculature or, better yet, stabilize existing vasculature to hypoxic damage. This may be possible through the use of autologous bone marrow (BM) or cord blood derived hematopoietic SC that selectively target sites of neovascularization and gliosis where they provide vasculo- and neurotrophic effects. We have demonstrated that adult BM contains a population of endothelial and myeloid progenitor cells that can target activated astrocytes, a hallmark of many ocular diseases, and participate in normal developmental, or injury-induced, angiogenesis in the adult. Intravitreal injection of these cells from mice and humans can prevent retinal vascular degeneration ordinarily observed in mouse models of retinal degeneration; this vascular rescue correlates with functional neuronal rescue as well. The use of autologous adult BM derived SC grafts for the treatment of retinal vascular and degenerative diseases represents a novel conceptual approach that may make it possible to "mature" otherwise immature neovasculature, stabilize existing vasculature to hypoxic damage and/or rescue and protect retinal neurons from undergoing apoptosis. Such a therapeutic approach would obviate the need to employ destructive treatment modalities and would facilitate vascularization of ischemic and otherwise damaged retinal tissue.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Neovascularización Fisiológica , Enfermedades de la Retina/fisiopatología , Enfermedades de la Retina/terapia , Vasos Retinianos/fisiología , Trasplante de Células Madre , Adulto , Células de la Médula Ósea/fisiología , Trasplante de Células Madre de Sangre del Cordón Umbilical , Endotelio Vascular/citología , Humanos , Vasos Retinianos/fisiopatología , Seguridad
2.
Expert Opin Biol Ther ; 4(12): 1887-96, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15571451

RESUMEN

Inflammation is initiated as a protective response by the host, but can often result in systemic pathology. Among cells of the immune system, T lymphocytes play a major role in the inflammatory response. T cell inflammation is characterised histologically by an infiltration of mononuclear cells. Key regulators of this response are a subset of T lymphocytes called T helper (Th) cells. These cells secrete soluble mediators called cytokines, which orchestrate the immune response. The appropriate regulation of Th cell immunity is critical in the control and prevention of diverse disease states. This review will focus on the role of Th cells in the inflammatory process involved in allergic disease, diabetes, infectious disease, rheumatoid arthritis, heart disease, multiple sclerosis and cancer. In the area of autoimmunity, in particular, a basic understanding of Th cells and cytokines has contributed to the development of clinically efficacious biological agents. This review also examines current and novel treatment strategies under investigation at present that regulate Th cell immunity, which may result in better treatments for immune-mediated diseases.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Células TH1/inmunología , Células Th2/inmunología , Animales , Antiinflamatorios/inmunología , Antiinflamatorios/uso terapéutico , Enfermedades Autoinmunes/tratamiento farmacológico , Antígenos de Histocompatibilidad Clase II/inmunología , Humanos , Inflamación/tratamiento farmacológico , Inflamación/inmunología
3.
Biochem Biophys Res Commun ; 317(3): 893-901, 2004 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-15081424

RESUMEN

Autologous cell therapies in neurodegenerative diseases and stroke will require an efficient generation of neuroprogenitors or neurons. We have previously shown that presumptive neural progenitors can be obtained from a candidate stem cell population isolated from adult skeletal muscle. Here we describe experimental conditions to isolate and characterize the cells with neurogenic potential from this population. Candidate stem cell population was isolated from adult skeletal muscle and expanded for selection during at least 30 cell divisions. FACS analysis revealed that this population was homogeneous with respect to CD45 (-), CD34 (-), and heterogeneous for CD90 (Thy-1) expression. The population was separated by cell sorting into three sub-populations based on CD90 expression (CD90-, CD90+, and CD90++) and each population expanded rapidly as free-floating spheres. When dissociated and plated in a neuronal differentiation medium, a large number of CD90+ cells acquired morphological characteristics of neuroprogenitors and neurons, and expressed markers of neurons but no markers of glial or muscle cells. In contrast, CD90- and CD90++ cells lacked this ability. Comparison of CD90+ and CD90- populations may be useful for studying the molecular characteristics defining the neuronal potential of stem cells from adult muscle. The selection of CD90+ expressing cells, combined with the growth conditions presented here, allows for rapid generation of a large number of cells which may be useful for autologous cell replacement therapies in the central nervous system.


Asunto(s)
Músculo Esquelético/citología , Células Madre/citología , Animales , Antígenos CD/inmunología , Diferenciación Celular , Separación Celular , Citometría de Flujo , Músculo Esquelético/inmunología , Ratas , Ratas Sprague-Dawley , Células Madre/inmunología
4.
Cell Biochem Biophys ; 40(1): 1-80, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-14983110

RESUMEN

Tissue restoration is the process whereby multiple damaged cell types are replaced to restore the histoarchitecture and function to the tissue. Several theories have been proposed to explain the phenomenon of tissue restoration in amphibians and in animals belonging to higher orders. These theories include dedifferentiation of damaged tissues, transdifferentiation of lineage-committed progenitor cells, and activation of reserve precursor cells. Studies by Young et al. and others demonstrated that connective tissue compartments throughout postnatal individuals contain reserve precursor cells. Subsequent repetitive single cell-cloning and cell-sorting studies revealed that these reserve precursor cells consisted of multiple populations of cells, including tissue-specific progenitor cells, germ-layer lineage stem cells, and pluripotent stem cells. Tissue-specific progenitor cells display various capacities for differentiation, ranging from unipotency (forming a single cell type) to multipotency (forming multiple cell types). However, all progenitor cells demonstrate a finite life span of 50 to 70 population doublings before programmed cell senescence and cell death occurs. Germ-layer lineage stem cells can form a wider range of cell types than a progenitor cell. An individual germ-layer lineage stem cell can form all cells types within its respective germ-layer lineage (i.e., ectoderm, mesoderm, or endoderm). Pluripotent stem cells can form a wider range of cell types than a single germ-layer lineage stem cell. A single pluripotent stem cell can form cells belonging to all three germ layer lineages. Both germ-layer lineage stem cells and pluripotent stem cells exhibit extended capabilities for self-renewal, far surpassing the limited life span of progenitor cells (50-70 population doublings). The authors propose that the activation of quiescent tissue-specific progenitor cells, germ-layer lineage stem cells, and/or pluripotent stem cells may be a potential explanation, along with dedifferentiation and transdifferentiation, for the process of tissue restoration. Several model systems are currently being investigated to determine the possibilities of using these adult quiescent reserve precursor cells for tissue engineering.


Asunto(s)
Diferenciación Celular/fisiología , Estratos Germinativos/citología , Células Madre Pluripotentes/citología , Regeneración/fisiología , Ingeniería de Tejidos , Factores de Transcripción , Animales , Antígenos de Superficie/metabolismo , Huesos/metabolismo , Bovinos , Linaje de la Célula/fisiología , Senescencia Celular/fisiología , Tejido Conectivo/fisiología , Proteínas de Unión al ADN/metabolismo , Diabetes Mellitus/terapia , Embrión de Mamíferos , Embrión no Mamífero , Extremidades/fisiología , Terapia Genética , Trasplante de Células Madre Hematopoyéticas , Humanos , Músculo Esquelético/metabolismo , Músculo Esquelético/trasplante , Infarto del Miocardio/terapia , Miogenina/metabolismo , Enfermedades Neurodegenerativas/terapia , Factor 3 de Transcripción de Unión a Octámeros , Células Madre Pluripotentes/trasplante , Ratas , Telomerasa/metabolismo , Urodelos/crecimiento & desarrollo , Urodelos/fisiología
5.
J Neurosci Res ; 69(6): 894-907, 2002 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-12205682

RESUMEN

Lineage uncommitted pluripotent stem cells reside in the connective tissue of skeletal muscle. The present study was carried out with pluripotent stem cells (PPSCs) isolated from 6-month old rat muscle. Before differentiation, these cells were vimentin+, CD90+, CD45-, and varied in their expression of CD34. The PPSCs were expanded as non-adherent aggregates under similar conditions to those used to generate neurospheres from embryonic or neural stem cells. The PPSC-derived neurospheres were positive for nestin, an early marker present in neuronal precursors, and expressed the two alternative mRNA forms of the neuroectodermal marker Pax-6, as well as mRNA for Oct-4, a gene related to the pluripotentiality of stem cells. To confirm their neural potential, PPSC-derived neurospheres were plated on coated coverslips under varying conditions: Neurobasal medium with N2 or B27, and either NT3 or BDNF. After 4-6 days the cells expressed neuronal (Tuj1+, NF68), astrocytic (GFAP) and oligodendrocytic (MOSP+, MBP+) markers, both by immunocytochemistry and RT-PCR. In addition, PPSCs were cultured as monolayers under adherent conditions, exposed to growth factors and defined differentiating conditions for 5 hr, and subsequently kept for 2 days in a maturation medium. At this point they gave rise to a mixed population of early neural progenitors (Nestin+ or NG2+), immature and mature neurons (Tuj1+ and NF145+) and myelin producing oligodendrocytes (CNPase + and MOSP+). Our study shows that PPSCs present in adult muscle can overcome germ lineage restrictions and express the molecular characteristics of brain cells. Therefore, PPSCs isolated from adult muscle could provide a novel source for autologous cell replacement in neurodegenerative and demyelinating diseases.


Asunto(s)
Músculo Esquelético/citología , Neuronas/citología , Células Madre/citología , Factores de Edad , Animales , Biomarcadores , Adhesión Celular/fisiología , Diferenciación Celular/fisiología , Células Cultivadas , Expresión Génica , Proteína Ácida Fibrilar de la Glía/genética , Proteínas del Tejido Nervioso/genética , Neuronas/fisiología , Oligodendroglía/citología , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA